ACell, Inc., a leading innovator in regenerative medicine, is headquartered in the United States, with significant operations across various regions. Founded in 1999, the company has established itself in the biotechnology industry, focusing on advanced wound care and surgical reconstruction solutions. ACell's core products, including its unique MatriStem® technology, utilise porcine-derived extracellular matrix to promote tissue regeneration and healing. This innovative approach sets ACell apart, offering effective solutions for complex wounds and surgical applications. With a strong market position, ACell has achieved notable milestones, including FDA approvals and partnerships that enhance its product offerings. The company continues to be at the forefront of regenerative medicine, committed to improving patient outcomes through its cutting-edge technologies.
We don't have data for ACell, Inc., but we can show you information about their parent organization instead.
View parent company